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WHILST there is little known about the pathology of agranulocytosis, little doubt
can be entertained as to the part played by the sulphonamide compounds in its
causation. Bigler, Clifton and WNerner (1938), Britton and Hawkins (1938), and
French (1939), amongst others, have demonstrated that sulphanilamide causes a
considerable fall in the number of white blood-cells without the actual appearance
of agranulocytosis, whilst, unfortunately, numerous cases of granulocytopenia have
been recorded following the use of this drug.
With the advent of MI&B 693 it was hoped that there would be less likelihood of
similar damage to the blood-cells of the body. Early reports seemed to promise
fulfilment of this hope: Evans and Gaisford (1938) found no difference in white-cell
counts performed on patients treated for pneumonia with the drug as compared
with those treated bv routine methods, despite the fact that very heavy dosage of
M&B 69:3 had been employecl. Fleming (1938) likewise fou'nd that the drug ha(d
no deleterious action on the leucocytes, at anv rate in vitro. Lloyd, Erskine and
Johnston (1938), however, noted a slight but definite depression of the total white
blood-cell couInt with polymorphonuclear leucopenia and a relative lymphocytosis
in a few of their patients who were being treated for gonorrheea. Somewhat similar
observations were made by Batchelor et al. (1938), Brown (1939), and Melton and
Beck (1939). The latter workers state that M&B 693 did not appear to affect the
red blood-cells: Long (1939), however, found that two cases of acute haemolvtic
anarmia occurred (luring administration of the drug at the Hospital of the
Rockefeller Institute. Unfortunately, as with sulphanilamide, a number of cases
of agranulocytosis following the use of M&B 693 have been recorded.
Following the introduction of M&B 693, heavy dosage of the drug was recom-
mended especially in the early stages of treatment, with the result that many
"minor" toxic maniifestations (i.e., nausea, vomiting, headache, depression, etc.)
were reported. The possibilities of more serious though less obvious toxic
manifestations became apparent, and the desirability of evolving a scheme of
dosage which would give the optimal clinical results with minimal toxic reactions
presented itself. rhis wvas of particular importance not only generally, but in view
of the fact that many of the patients treated were attending hospital as out-patients.
An investigation was accordingly carriedl out personally with these objects in view.
The cases investigated were chiefly out-patients being treated for gonorrhcea. The
following are some of the results of this investigation.
The reaction of patients on Uleron therapy was also studiedl in a smaller series
of cases.
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FPROCEDURE.
SixtN-one male patieints were investigatedl: fifty-nine were suffering from
gonorrhcra and two from staphylococcal urinary infection. Of these, fifty were
patients treate(I with 'M&B 693, seven were treated with Uleroni, and four were
normal conitrols. Ihe fifty patients on M&B 69.3 were divided into three groups
A, B, and C:-
Group A.-This consists of forty-four out-patients who had the same dosage over
a period of seven days (with occasional slight variations) ; during the first day
they were given 3g. of the drug, whilst 2g. per cday were a(lministered thereafter
for a further six days.
Group B.-(iroup B3 consists of four patients to whom heavier dosage over a
more proloniged period was adlministered as follows:-
(I). Pt.Sh. 42.5g. in thirteeni days (in-patient suffering from epididyymitis).
(II). Pt.L. 17.5g. in ten (lavs (ini-patient suffering from staphylococcal urinary
infection and( para-urethral abscess).
(III). Pt.B. 24.0g. over a period of twenty-five days, which included seventeen
days' interval (out-patient suffering from gonorrhoea)
(IV). P't.Sc. 45.0g. over a period of twenity-three days, which included three days'
initerval (out-patient suffering from gonorrhoea).
Grou(p. C.-In two cases, a daily or bi-daily blood investigation was performed
over a period of six days following single doses of M&B 693 of 4g. and 2g.
respectively.
The patients on Uleron were given 3g. of the drug per day for four days, followed
by a period of seven to eight days' rest, when a second "stoss" similar to the first
was administered, and, after a further interval of rest as before, a third "stoss"
was given. The normal controls were four out-patients who were being treated
by routine methods of urethral irrigations and mixed gonococcal vaccine.
Serial total and (lifferential white-cell counts and red-cell counts were made wZith
ordinary standard pipettes, the hamoglobin being estimated by the Sahli method.
In order to lessen the known daily fluctuations in the cell counts as much as possible,
the counts were performed as nearly as possible at the same time each day, whilst
to ensure the maximum degree of accuracy in the actual whitc-cell counts them-
selves, the following points were observed:
(I). In the estimation of total leucocytes, four preparations were made, and the
four counts thus obtained were averaged.
(IJ). In the estimation of the differential count, at least four hundred unselected
white blood-cells were examined, and in many cases considerablv more
than this number werc counted.
Normal rea(lings were taken as follows
Hemoglobin - - - - 99-100 per cent.
Red blood-cells - - - - 5,100,000 to 6,350,000
Total leucocytes - - - - 5,000 to 10,000
84Total IPercentage of
Differential Counts -- r cmlm. l()tal Leucocytes.
Neutrophil polymorphonuclear leucocytes - 3,000-6,000 60-70
Lymphocytes - - - - 1,500-2,700 25-30
MonocN-tes - - - - 350- 800 5-10
Eosinophil polymorphonuclear leucocytes - 150- 400 1- 4
Basophil polymorphonuclear leucocytes - 0- 100 0- 1
Anything above or below these figures was considered to be abnormal.
In the patients taking MI&B 693, blood investigations were performed whilst the
drug was being taken and for a varying period thereafter up to the end of
thirty-two days from the commencement of chemotherapy (and occasionally for an
even longer period). In order to ascertain as nearly as possible the exact day on
which the maximum effects, if any, vere seen, the investigations were carried out
on different days on different patients, so that a fairly complete daily series was
obtained during the period of examination. As the majoritv of bloodl counts were
performed up to and including the twenty-second day from the beginning of
chemotherapy, the results will be considered in detail only up to that day, but
reference xwill be made to results obtained at an even later period. In the case of
Uleron patients, blood investigations were performed before the beginning and at
the end of each "stoss" and finally a week after the end of chemotherapy. lInvesti-
gations were carried out at frequent intervals over a period of tw-o weeks on the
control cases.
RESULTS.
Blood Cell Changes with M&B 693.
Grouip A-Forty-foutr Patienits on the Same Dosage.
I OTAL LEUCOCYTES.
The average total leucocvte count for the forty-four patients showed a distinct
drop both during chemotherapy and for some considerable time after (liscontinuing
the drug, reaching its lowest point on the sixteenth day (i.e., nine (lays after the
end of chemotherapy). -\fter this the count rose again. Ihough the average
figure (lid not reveal a leucopenia at anly time, eight indlividual cases (or just over
eighteen per cent. of the series) gave a total leucocyte counit of less than 5,000 per
cmm. on one or more occasions. Of these, the lowest count coincided with the third
day after commencing chemotherapy in one case, the fourth day in tw%ro cases, the
fifth dav in one case, the eighth day in four cases, and the eighteenth day in one
case, so that, though the dlifference was small, the greatest number of cases of
leucopenia occurre(d after the withdrawsal of the drug, the maximum numiiber being
seen on the day immediately following the endl of chemotherapy. The lowest figure
recorded was 4,062 on the eighth day on a patient wvhose original white-cell count
had been 9,687.
85D)IFFERENTIAL LEUCoCYTE COUNTS.
Polvinorphlonuclear Ne( t h'p/il Leicocytes. (NeuIirophlils).
It became evident that the downward trend in the average total leucocyte count
was due to a fall in the number of the neutrophil leucocytes. Here again the
lowest total count occurred on the sixteenth day, xhen a figure of 2,888 cells per
cmm. was recorded, so that an actual average neutropenia was observed on that
day. Actually approximately thirty-two per cent. of the series showed a neutropenia
on one or more occasions, the lowest figure recorded being 1,960 cells per cmm. on
the eighth day, on the patient mentioned before as having the lowest total leucocyte
count: this was the only occasion on which a count of below 2,000 cells per cmm.
was recorded in this series.
Whilst a definite neutropenia was tllus observed, the most striking feature in
the investigation of the white cells was not the changes in the total neutrophil counts
so much as a marked variation in the percentage of neutrophils present.
It was observed time after time that the percentage of neutrophils decreased,
and again it wvas found that the maximum effect appeared on the sixteenth day.
Actually approximately eighty-three per cent. of the cases in this group showed a
fall in neutrophils on one or more occasions to below sixty per cent. of the total
leucocytes : 36.6 per cent. showed a fall to between forty and fifty per cent. of
the total leucocNtes, whilst 9.7 per cent. of cases actually fell to below forty-five
per cent. of the total white cells. rhe lowest figure recorded was 41.75 per cent.
on the eighth day in a patient whose neutrophils had been 64.5 per cent. of the
total leucocytes before chemotherapy was commenced.
Lyttmphocytes.
The average total lymphocyte count showed a fairly steady level throughout,
though actually 36.6 per cent. of cases showed a slight lymphocytosis of
more than 2,700 cells per cmm. on one or more occasions. 24.4 per cent. were
above 3,000 cells per cmm. at some time during the investigation, the highest figure
reached beinig 3,811 in one case on the nineteenth day.
As was to be expected, as a result of the changes in the neutrophils, a marked
variation in the percentage of lymphocytes present was seen, increasing as the
neutrophils decreasedl. Thus 76.6 per cent. of the cases showed more than
thirty per cent. of lymphocytes in their differential counts on a number of occasions,
24.4 per cent. of the total having more than forty per cent. of lymphocytes at some
period. Tlhe highest percentage recorded was 43.25 in one case on the sixteenth day.
Though variations in the number of lymphocytes are usuall)y relative, and depend
merely on the number of polymorph cells present, absolute increase is not unknown.
It is difficult to state where an absolute increase in lNmphocytes has occurred in the
present series. French (1939), in her investigations on the action of sulphanilamide
on the blood, considered that all cases showing a total leucocyte count of 10,000
or more per cmm., and in which the lymphocytes numbered thirty or more per cent.,
represented a true lymphocytosis. Oii this basis, 9.7 per cent. of cases in this
present series showed an absolute lymphocytosis, though 7.3 per cent. also had a
neutrophil couLnt of less than sixty per cent. at the samile timie.
86Motnonutclear Leucocvtes. (Mllonocvptes).
Though the average number of monocytes present ten(led to show a slight fall,
there was a consi(lerable variation in the findings recorded, and the average
number kept well within the limits of normalitv throughout. Actually in 29.5 per
cent. of cases a monocytosis of over 8000 cells per cmm. was found, the greatest
number being 1,291 on the fourth day in one patient.
Here again, greater variation was seen in the percentage of cells recorded. In
forty-five per cent. of the patients in the series, a reading of over ten per cent. of
monocv,tes was observed, the highest being 14.75 per cent. in one case on the
fourth day.
Eosinophzil and Basop/iil Polvynorphonuclear Leutcocytes.
(Eosiniophils and Basophils).
Neither the eosinophils nor basophils showed any constant change. The
highest recorded figure of the series for the eosinophils was 12.75 per cent. or 1,187
cells per cmm. on the eighth day in one case who, however, tended to show a high
eosinophil count throughout.
Hcenioglobin and Red Blootd-cells.
Little variation w,as seeni in the hxmoglobin throughout the entire series, though
several cases showed a slight fall at some time or another; this was most marked
in one patient wlhose haimoglobin fell from ninety-one per cent. before chemotherapy
was started, to eighty-one per cent. on the sixteenth day. Five days later, however,
it had risen to eightv-five per cent. A slight but significant fall was noticed,
however, in the average red blood-cell count, and again this was most
marked at the fifteenth and sixteenth davs, when average counts of less than
5,000,000 red cells per cmm. xvere recorded. Actually 37.5 per cent. of cases
showed a count of less than 5,000,000 red blood-cells at some time or other during
the period of investigation. The lowest recorded red-cell count was 4,170,000 on
the eighth day on a patient whose count before chemotherapy had been 5,010,000
per cmm. In the majority of cases, the reduction in the number of red blood-cells
was of a much more transient nature than that of the white cells.
Grolup B-Four Patients onz fleavier Dosage.
In view of the fincdings recor(led above, it was interesting to note that whilst the
patient -who hadl the largest (lose of the series (45g. over a period of twenty-three
days) shoxved somewhat similar changes in the white cells to those already observed,
these changes were much less pronounced than one would have expected, and the
blood picture had returned to normal several days before the end of chemotherapy.
There was Ino subsequent fall in the number of cells during the following eighteen
days, ancd in fact the neutrophils increased to over seventy per cent. of the total
leucocytes and remainied high during the period of observation mentioned, following
the with(drawal of the dcrug. This patient ha(d not responded to chemotherapy, and
it was tempting to believe that possibly the drug was being poorly absorbed
(unfortunately, the absorption and excretion were not investigated), and subse-
quently had little deleterious effect either on the organisms causing the disease, or
on the blood-forming organs of the body.
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GAn examiniiKationi of the effects of the (drLg on the blood in five patients in Group A
who either did not respondl to chemotherapy or who showeed subsequent relapse,
revealed somewhat similar changes in four cases to those noted in the majority of
patients; in three of these, however, the changes wvere of a transient nature only.
The fifth patienit showed no decrease in the number of the bloo(d cells at all.
An investigation was consequently ma(le in thosc patients in xvhom absorption and
excretion of the drug had been simultaneously studied with the blood-cell changes,
in order to see whether or not the changes in the blood cells varied in proportion
to the concentration of the free drug in the blood. There was no constant relation-
ship found between the two (see Table).
i'lie patient xho received the second largest (lose (42.5g. in fifteen davs, Pt. S.
in Iable) again showed similar changes to those in Group A., the maximum effect
on blood cells being noticedl eleven days after withdrawal of the drug, when the
neutrophils fell to 40.5 per cenit. of a total leucocvte count of 5,625, the lymphocyte
count rising to 48.25 per cent.
Very similar eflects were observed in both of the other cases in this group. It
was initeresting to note that the effects with the larger doscs were not necessarily
more pronoUn1Ced than with the small dlosage which had been used for the patients
in Group .\.
(roup C(-T7Wo Patients on a Single Dose of M&B 693.
In both of these cases variation was slight, though in one (following 2g.) there
was a ten(leney to irregularity. As this patient's blood-cell counts were just on the
border-line of normalitv at the beginning, it was (lifficult to be sure that any
subsequent change was due to the drug.
Bloodl Cell Changes with Uleron.
\Vhilst the niumLlber of cases of Uleron-treate(d patients which was studied was
admittedly smaller than those on M.NI&B 693, it w\-as clear that Uleron had
an even more marke(d toxic effect ont the white and red blood-cells than
M&B 693, and that this effect was more noticeable at the end of the
third "stoss" an(d continued for some days after withdrawal of the drug. The
effect on the leucocytes was again chiefly due to a fall in the number of neutrophil
polymorphonuclear cells, though the monocvtes also showed a greater numerical
re(lICtion than with 'M&B 693. SeventN-one per cent of cases sho-wed leucopenia
at some time or other, the lowest figure being 3,437 leucocytes per cmm. at the end
of the third "stoss" in one patient where the original leucocvte counIt had been
8,1205 cells per cmm. AIn absolute neutropeinia was seen in forty per cent. of cases,
whilst another twenty per cent. showed relative neutropenia, the lowest figures
being respectively 1,873 neutrophils per cmm. at the end of the third "stoss" in
one case w\,here the originial count ha(d beeni 5,545 neutrophils per cmm., and 41.75
per cent. of the total leucocvtes at the end of the first "stoss" in another case,
where the original percentage ha(l been 59.75.
No marke(d changes were seen in the lymphocytes except those conlsequent upon
the neutrophil variations, whilst the basophils and eosinoplhils varied little: the
latter cells were rather loW throughout.
88The fall in the lmhcer of redl blOO(l-cells was agnin exvident, but as
before, these changes were of aimore transient natuI-r thiani those observed in the
leucocytes. Sixty per cenlt. of cases slo0xed(l a decrease in the iunmber of the red
cells to below\\,5,000,000 per cmm. at some time or other.
Normal Controls.
No abnormiial -ariationis were seen in the blood-cell count or hlemoglobill in the
control cases.
DISCUSSION.
An examinationi of the results obtained in this series of cases leaves little room
for doubt that even comparatively small (loses of both M&B 693 and Uleron cause
considerable damage to the blood-cells of the body%. Tlhat the redl cells (1o not
escape the destructive process is demonstrated by the results obtained in the rcd-cell
counts. Ihis is rather at variance with the observations made by MIelton anid Beck
(1939). Dolgopol and Hobart (1939), however, in a fatal case of agranulocvtosis
following .M&B 6983 (lescribed by them, found that, whilst the action of the drug
on the bone-marrowz apparently coinsiste(d mainly in the arrest of maturationi of the
leucopoietic elements, the ervthropoietic elements were also considerably affected.
It has been mentionc(d that at least two cases of acute hemolvtic anwmia have
been described by Long (1939). The toxic effect, however, would appear to beimore
markedl on the white-cell elemenits: that there is a definite tendency to a lowering
of the total leucocvte count, and that this is due to a fall in the number of
neutrophils, has been shown. That a similar phenomenon is observed after the
administration of sulphanilamide has been recor(led bv Britton anld Hawkins (193,8)
and French (1939), so that the action of \I&B 693 on the bloodl cells would appear
to be essentially similar to that of sulphanilamide. Whilst the fall in the number
of the total leucocvtes and the absolute neutropenia in the present series is rather
less than that recorded by Britton and Hawkins (1938), the dosage of M&B 693 is
considerably smaller than that of sulphanilamide in the investigation made by
these two workers. French (1939) found that only :33.3 per cent. of her sulpha-
nilamide-treated cases gave a neutrophil-count below sixty per cent. of the total
leucocytes. That M&B 693 has an even more toxic action on the white cells than
sulphanilamide would seem to be indicated by the fact that eighty-three per cent.
of cases in the present series exhibited a (crop at some time or other in the neutrophil-
count to below sixty per cent. of the total leucocytes. This relative netutropenia,
together with an accompanying relative lymphocytosis, was so marked that one
almost came to regard it as a usual feature in patients who were being treated
with M&B 693. Lloyd andl his associates (1938) noted a slight but definite fall in
the total white blood-cell count with polvmorphonuclear leucopenia, and a relative
lymphocvtosis in a few of their patients who were being treate(d with this drug
unfortunately, they do not state the nunmber of patients in whom the investigation
was carried out, nor the percenitage showing this phenomenon.
It is difficult to see just why this toxic effect on the red-cell elements on the one
hand andI the white-cell elements on the other should be more marked in some
patients thani others, and why in some cases it should proceedl to acute hwmolytic
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HTABLF.-
The relationship between the concentration of free AM&B
blood, the percentage of acetylated drug present in the
blood-cell changes.
Average
Conc. of
Free
PATI ENT M&B 693
in the
Blood
(Mgms. %%)
GROUP A
M1238 2.98
\11373 4.1
M1038 3.66
M71 3.02
1.707 2.5
GROUP B
Pt. L 2.2
Pt. S 3.67
18.1
20.0
20.7
14.4
27.6
18.3
28.2
per cmm.
13,750
10,625
10,312
9,867
10,625
per cmm.
8,594
7,836
6,085
5,982
6,481
16,250 12,317
7,500 5,362
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62.5
73.75
59.0
61.75
61.0
75.8
5,611
5,l9
5,924
5,10
16,11~
71.5 5,094,Absorption and Excretion of Nl&B 693
Werner's (1939) method.
was studied bv
BLOOD-COUNTS AF-rFR CHEMOTHERAPY
bwest Lowest Lc
ToW Total Percentage R
*octes Neutrophils Neutrophils per
i cm,. per cmm.
_ __ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~I
I -n 11 rwc IA n C ,1851
1,187
,562
062
"875
1625
.,625
4,061
3,248
1,960
3,139
4,312
2,278
'I L.)
56.5
49.5
48.25
45.66
")LU
)west RESULTS
.B.C.
cmm.
,o000 Failure
REMARKS
Showed a decrease
in number once
only (4th day).
5,420,000 Relapse Showed a decrease
tw ice only (4th
and 8th days).
6,64
5,01
- Cure Decrease on the 3rd
day from begin-
ning of chemo-
therapy.
90,000 Cure Decrease once as
here, slight on
20th day again.
00,000 Cure Decrease five times
-most marked
on 14th day.
46.0 5,120,000 Cure
40.5 5,380,000 Cure
Decrease several
times, including
once beyond the
23rd day from
commencement
of "693."
Decrease on 11th
day after finish-
ing chemotherapy
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NOTE.-
JI,754a.lemia or agranulocvtosis. I'hlat it unfortunatelb does, however, has alrea(ly been
mentioned. Ihis disturhance does not seemn to (lepencd ulponI the concentration of
the (Irug in thle blood, as patienits with low blood concentrationis may show ani even
more marked l)lood-cell disturbalnce than those cases -where the concentration is
comparatively high (see Table). In the fatal case recorded by I)olgopol and Hobart
(19:39), the highlest blood concentration was ten milligranimes per hundred c.c.,
but other patients have shown conicentrationis of a much highler standard even than
this without apparenit ill-eflect. Most of the patients in whonm agranulocytosis has
beeni observed, have had comparatively high (losage of the drug, and it would
seem that this plays an importanit par-t in the pathological process. A comparison
of an analysis of a numiiber of reports of recor(ded cases of granulopenia following
chemotherapy with M&B 6983 vitl those following sulphanilamide reveals the fact
that, whilst the average (lose of NI&B 693 adminiistered in these cases is similar
to that of sulphanilamnide, the average perio(d of administration is rather less than
for thc latter (drug: it is suggestive that the total dosage of M&B 693 is of even
more importance thani the period of administration. This findls support in two
cases of granulopenia recorded by Briggs (1939): AI&B 693 was given over an
equal perio(l of ninie days to each patient; one case, however, had 60g. of the
(lrug, whilst the otlher had 49g.: the patient with the larger dose manifested the
more sexvcre s!ymptoms. It is possible that an undue sensitivity to the drug is
exhibite(d in these cases, wlhilst the toxic actioni of the causative organism on the
blood-forminlg tissues undoubtedly plays a part in some of the more serious
conditions treated (Colebrook, 1939).
It appears to be imiipossible to foretell just which patient is liable to develop a
serious bloo(d dlvscrasia and wvhich is not. Ihat the onset of agnranulocytosis has
been of such dranmatic su(ldenness that even repeated bloodl-cell counts have failed
to indicate its approach has, unfortunately, been recordled with sulphanlilamide
(Young, 1937). Nexertlheless, a repeated blood-cell investigation shouldl form an
integral part of sulphonaimii(le chemotherapy, especially where a dosage of 20g.
or over (Pringle et al., 1940) is being given to a patient suflering from a condition
likely itself to dlamage the bone-marrow. A number of other factors are significant
in recor(le(l cases of agranulocytosis, and in particular it would seem to be of first
importance to keep a close watch on the blood-cells of those patients who show
undue signs of toxicity or an atypical response to the drug. IThat patients who do
not show a rapidl response to chemotherapy arc unlikely to responid at all has been
the experience of most workers. In such patienits, it seems evident that chemo-
therapy should be stopped anid other means of treatment instituted.
\With regar(d to the cell-counlts themselves, it has been dlemonstrated that the
detrimeintal effect of MI&B 6983 continiues for somc days aIfter withclrawal of the
drug, and that the maximuLm toxic effect is often seen (lurilig this period: in the
investigation described, the grcatest effect was witnessed about nine days after
cessation of chemotherapy and( sometimes even later. TIhis delayed efect has been
the experience of other workers also (Barnett et al., 1939.), (Graham et al., 1939),
(Agranat et al., 19:39, an(l Brig,-gs, 1939). It is impor-tant, therefore, that where
92large dosage of the drug has been employed, and especially if there have been any
signs of undue toxicity or unusual response to chemotherapy, the blood investiga-
tions should be continued for at least ten to fourteen days after the drug has been
stopped.
SUMMARY.
(1) M&B 693 and Uleron, in common with other sulphonamides, cause a fall in
the number of the red ancl white blood-cells of the body. The effect is greatest
on the neutrophils and is more marked with Uleron.
(2) This effect continues after withdrawal of the drugs and may reach its maximum
during this period.
(3) The effect on the blood-cells is not proportional to the concentration of the
free drug in the blood, and differences must often be attributed to indlividual
variations in the susceptibility of the bloocd-forming tissues.
(4) Repeated blood-cell counts should be performed oni patients takinig these drugs,
both during chemotherapy and for ten to fourteen days after withdrawal of
the drug, especially where large dosage has been employed or where toxic
symptoms or atypical response to chemotherapy have been observed.
I am indebted to Dr. J. C. Rankin of the V.D. Clinic, Royal Victoria Hospital,
Belfast, and to Professor E. B. C. Mayrs of the Department of Pharmacology in
Queen's University, Belfast, for their helpful advice and criticism. Mvs thanks are
also due to Messrs. May & Baker Ltd., and to Messrs. Bayer Products Ltd., for
free supplies of much of the material used in the earlier part of this work.
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